DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+13.3%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$118M
AUM Growth
+$118M
(+3.9%)
Cap. Flow
-$3.17M
Cap. Flow
% of AUM
-2.68%
Top 10 Holdings %
Top 10 Hldgs %
44.84%
Holding
84
New
18
Increased
12
Reduced
22
Closed
12
Top Buys
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
$6.77M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
$3.99M |
| 3 |
CLLS
Cellectis
CLLS
|
$1.83M |
| 4 |
Rigel Pharmaceuticals
RIGL
|
$1.57M |
| 5 |
BLRX
BioLineRX
BLRX
|
$961K |
Top Sells
| 1 |
Galapagos
GLPG
|
$2.65M |
| 2 |
Cytokinetics
CYTK
|
$2.56M |
| 3 |
DERM
Dermira, Inc.
DERM
|
$2.41M |
| 4 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$2.34M |
| 5 |
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
|
$2.1M |
Sector Composition
| 1 | Healthcare | 85.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
| $12.7M | 10.7% | 300,722 +161,000 | +115% | +$6.77M |
|
2
AtriCure
ATRC
$1.84B
| $9.71M | 8.21% | 506,946 -12,000 | -2% | -$230K |
|
|
NXTM
3
DELISTED
NxStage Medical Inc.
NXTM
| $5.8M | 4.9% | 216,119 -20,000 | -8% | -$537K |
|
|
ALDR
4
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $4.6M | 3.89% | 221,013 | – | – |
|
|
5
BioCryst Pharmaceuticals
BCRX
$1.74B
| $4.55M | 3.84% | 541,128 +475,228 | +721% | +$3.99M |
|
|
VIRX
6
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $3.56M | 3.01% | 867,529 -266,054 | -23% | -$1.09M |
|
|
BPMC
7
DELISTED
Blueprint Medicines
BPMC
| $3.3M | 2.79% | 82,500 +10,000 | +14% | +$400K |
|
|
8
Galapagos
GLPG
$2.07B
| $3.05M | 2.58% | 35,359 -30,709 | -46% | -$2.65M |
|
|
ONC
9
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $2.97M | 2.52% | 81,231 -38,610 | -32% | -$1.41M |
|
|
AGTC
10
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $2.84M | 2.4% | 411,000 +124,702 | +44% | +$860K |
|
11
Ardelyx
ARDX
$1.53B
| $2.81M | 2.37% | 221,738 +47,743 | +27% | +$604K |
|
12
Insulet
PODD
$23.9B
| $2.74M | 2.31% | 63,484 -10,000 | -14% | -$431K |
|
13
Spyre Therapeutics
SYRE
$996M
| $2.61M | 2.21% | 350,392 | – | – |
|
14
iShares Biotechnology ETF
IBB
$5.6B
| $2.55M | 2.16% | 8,700 | – | – |
|
15
Neurocrine Biosciences
NBIX
$13.8B
| $2.53M | 2.14% | 58,508 -7,500 | -11% | -$325K |
|
16
MacroGenics
MGNX
$112M
| $2.22M | 1.88% | 119,200 +30,000 | +34% | +$558K |
|
|
BEAT
17
DELISTED
BioTelemetry, Inc.
BEAT
| $2.17M | 1.84% | 75,000 | – | – |
|
|
AERI
18
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.12M | 1.79% | 46,770 -51,600 | -52% | -$2.34M |
|
|
SPNC
19
DELISTED
Spectranetics Corp
SPNC
| $1.91M | 1.61% | 65,496 | – | – |
|
|
RDUS
20
DELISTED
Radius Health, Inc.
RDUS
| $1.89M | 1.6% | 48,809 -5,045 | -9% | -$195K |
|
|
CLLS
21
Cellectis
CLLS
$258M
| $1.83M | 1.55% | +76,404 | New | +$1.83M |
|
|
TVRD
22
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $1.75M | 1.48% | 95,322 -114,200 | -55% | -$2.1M |
|
|
IMMU
23
DELISTED
Immunomedics Inc
IMMU
| $1.63M | 1.38% | 252,574 -307,100 | -55% | -$1.99M |
|
24
Cidara Therapeutics
CDTX
$1.66B
| $1.63M | 1.38% | 208,458 +48,540 | +30% | +$379K |
|
|
FOMX
25
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1.61M | 1.36% | 325,667 +57,600 | +21% | +$285K |
|